Pill for advanced pancreatic cancer shows promise
A once-a-day pill for advanced pancreatic cancer has wiped out the disease in one in 12 patients when combined with chemotherapy, a clinical trial suggests.
Fresh headlines from around the world. Gaming, politics, technology and everything in between.
A once-a-day pill for advanced pancreatic cancer has wiped out the disease in one in 12 patients when combined with chemotherapy, a clinical trial suggests.
Daily pill daraxonrasib appears to shrink and possibly even eliminate tumours in some patients with one of the deadliest cancers.
A powerful new AI system could help doctors detect pancreatic cancer years before it becomes visible on conventional scans. The technology, called REDMOD, identified hidden warning signs an average of 475 days before diagnosis and was nearly twice as sensitive as experienced radiologists. By spotting cancer-related changes at their earliest stages, it could
Scientists have discovered how pancreatic cancer cells continually reshape their genetic makeup to become more aggressive, spread, and evade treatment. In laboratory experiments, blocking a key gene reversed some of these dangerous changes, revealing a potential new way to fight the deadly disease.
Amplia Therapeutics has advanced its cancer drug narmafotinib across four trials, with data suggesting it may work independently of common tumour-causing KRAS gene mutations.
Source: National Cancer Institute - Related MedlinePlus Pages: Pancreatic Cancer
Allnira republishes accessible articles under owner-declared permissions, with original authors, publishers and image credits. Automatic cloud imports run hourly; open pages check for updates every 15 seconds. Publication delays depend on each feed.